Trident Lifeline Limited Share Price & Stock Analysis

Trident Lifeline Limited (BSE: 543616) is a Surat, Gujarat-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹511 Cr, it ranks #1,995 by market cap among the 6,197 Indian listed companies on FinBizNet, and #8 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹421.00 (as of 16 Nov 2026), the share price is 4.8% below its 52-week high of ₹442.00 and 83.1% above its 52-week low of ₹229.95. The share price is up 37.6% over one year and up 60.5% over three months.

Key Metrics

Current Price₹421.00
Market Cap₹511 Cr
BSE Code543616
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
P/E Ratio26
Return on Assets7.31%
52-Week Range₹229.95 – ₹442.00
1-Year Price Change+37.6%
3-Month Price Change+60.5%
Beta (1Y)0.05
Dividend Yield0.24%
HeadquartersSurat, Gujarat
Websitetridentlifeline.com

Shareholding and Delivery

Promoters held 73.68% of Trident Lifeline Limited's shares as of Jun 2026, unchanged from Jun 2025. Delivery averaged 79.7% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Trident Lifeline Limited

Trident Lifeline Limited, together with its subsidiaries, manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. The company offers various medicinal products, including pharmaceuticals, nutraceuticals, herbals, and injectables in the form of tablets, capsules, dry powders for oral suspension, oral liquids, ointments, liquid ointments, effervescent tablets, sachets, pastes, gels, solutions, suspensions, ice gels, syrups, and creams, as well as toothpaste and mouthwash. Its products target a range of therapeutic solutions, such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, dental cure, proton pump inhibitor, antiprotozoal, antihistamine, antihypertensive drugs, antiparasitic, antilipidemic drugs, multivitamins, multiminerals, and non-steroidal anti-inflammatory drugs. The company is also involved in the manufacturing of formulations under proprietary brands; contract manufacturing arrangements; manufactu

Products and Services

1. Sale of Pharmaceuticals Products-This segment engages in the pharmaceutical business. Its product portfolio comprises of a range of drugs, such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental cure, proton pump inhibitor, anti-protozoal, anti-histamine, anti-hypertensive, anti-lipidemic, anti-parasitic, multivitamins, multimineral nyteraceuticals, and non-steroidal anti-inflammatory drugs. This segment is also involved in the distribution of pharmaceutical products. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Sale of Pharmaceuticals Products-100%

Trident Lifeline Limited vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Infinium Pharmachem Limited₹436 Cr36.410.54%—+11.7%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Trident Lifeline Limited?

Trident Lifeline Limited is trading at ₹421.00, with a market capitalisation of ₹511 Cr.

Which sector does Trident Lifeline Limited belong to?

Trident Lifeline Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What are the key financial ratios of Trident Lifeline Limited?

Trident Lifeline Limited has a P/E of 26.

What is the stock symbol of Trident Lifeline Limited?

Trident Lifeline Limited is listed on the BSE under the scrip code 543616.

How has Trident Lifeline Limited's share price moved over the past year?

Trident Lifeline Limited's share price is up 37.6% over one year and up 60.5% over three months. Its 52-week range is ₹229.95 to ₹442.00.

What is the promoter holding in Trident Lifeline Limited?

Promoters held 73.68% of Trident Lifeline Limited's shares as of Jun 2026, unchanged from Jun 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.